No Data
No Data
Evercore ISI Keeps Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
Promising Potential of Epetraborole in Treating MAC Lung Disease Drives Buy Rating for AN2 Therapeutics
AN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)
Insider Spends US$213k Buying More Shares In AN2 Therapeutics
Insider Purchase: Director at $ANTX (ANTX) Buys 5,000 Shares